Among significant research news last week, US biotech Allakos reported that it was dropping development of its urticaria ...
Sage Therapeutics rejects Biogen deal offer; Silvus Technologies considers sale/IPO; Allakos downsizes; MrBeast bids on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback